Cargando…
The regulatory role of aberrant methylation of microRNA-34a promoter CpGs in osteosarcoma
BACKGROUND: The methylation of microRNAs (miRNAs) and DNA play an important role in the development of tumors. MiRNA-34a can inhibit the proliferation and metastasis of osteosarcoma cells. It was approved in a variety of tumors studies that abnormal promoter methylation leads to the reduction of miR...
Autores principales: | Shi, Jiandang, Zhao, Chen, Liu, Xuejiao, Zhang, Bing, Wang, Peng, Yang, Zongqiang, Niu, Ningkui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798479/ https://www.ncbi.nlm.nih.gov/pubmed/35116985 http://dx.doi.org/10.21037/tcr.2019.09.47 |
Ejemplares similares
-
CpGs relieve arthritis
por: Bashyam, Hema
Publicado: (2007) -
Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
por: Hubertus, Jochen, et al.
Publicado: (2013) -
Thousands of CpGs Show DNA Methylation Differences in ACPA-Positive Individuals
por: Zeng, Yixiao, et al.
Publicado: (2021) -
Sparse conserved under-methylated CpGs are associated with high-order chromatin structure
por: Lin, Xueqiu, et al.
Publicado: (2017) -
Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
por: Kagami, Masayo, et al.
Publicado: (2019)